Axoltis Pharma
Pre-clinicalOur vocation is to develop first-in-class innovative drugs to treat patients with degenerative or traumatic neurological disorders with high unmet medical needs.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Our vocation is to develop first-in-class innovative drugs to treat patients with degenerative or traumatic neurological disorders with high unmet medical needs.
RNA & Gene Therapy